tiprankstipranks
Cytokinetics (CYTK)
NASDAQ:CYTK
Holding CYTK?
Track your performance easily

Cytokinetics (CYTK) Financial Statements

995 Followers

Cytokinetics Financial Overview

Cytokinetics's market cap is currently ―. The company's EPS TTM is $-5.388; its P/E ratio is -9.25; Cytokinetics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-1.25. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 463.00K$ 249.00K$ 835.00K$ 1.67M$ 378.00K
Gross Profit$ 463.00K$ -79.35M$ -80.73M$ -162.72M$ -82.15M
EBIT$ -140.80M$ -119.02M$ -118.32M$ -119.83M$ -115.43M
EBITDA$ -138.39M$ -116.61M$ -115.99M$ -113.50M$ -113.57M
Net Income Common Stockholders$ -160.54M$ -143.32M$ -135.64M$ -136.90M$ -129.42M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.01B$ 1.06B$ 618.96M$ 614.82M$ 539.24M
Total Assets$ 1.44B$ 1.52B$ 808.08M$ 824.32M$ 740.61M
Total Debt$ 238.15M$ 239.58M$ 205.13M$ 206.78M$ 200.34M
Net Debt$ -773.55M$ -817.20M$ -413.83M$ -408.04M$ -338.90M
Total Liabilities$ 1.45B$ 1.42B$ 1.20B$ 1.21B$ 1.18B
Stockholders Equity$ -13.91M$ 108.55M$ -396.16M$ -386.32M$ -438.80M
Cash Flow-
Free Cash Flow$ -102.20M$ -101.23M$ -129.50M$ -74.11M$ -96.42M
Operating Cash Flow$ -101.50M$ -99.32M$ -129.50M$ -74.04M$ -96.20M
Investing Cash Flow$ -45.05M$ -651.55M$ 32.64M$ -81.41M$ 73.04M
Financing Cash Flow$ 3.42M$ 821.01M$ 103.79M$ 168.80M$ 54.22M
Currency in USD

Cytokinetics Earnings and Revenue History

Cytokinetics Debt to Assets

Cytokinetics Cash Flow

Cytokinetics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis